Idexx Laboratories (IDXX): Rep. April McClain Delaney (MD06) disclosed a partial sale $1K–$15K
Rep. April McClain Delaney (MD06) disclosed a partial sale of Idexx Laboratories in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 6 days
- Disclosure lag
- Traded
- Oct 29, 2025
- Disclosed
- Nov 4, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 1, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
- Aug 7, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
- Sep 4, 2025Congress · 1 personMembers of Congress: 2 purchases
- Oct 6, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective October 6, 2025, the board of directors (the “Board”) of IDEXX Laboratories, Inc. (the “Company”) elected Karen Peacock as an independent Class I Director and appointed her as a member of its Compensation and Talent Committee and Finance Committee.”
- Oct 16, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
- Oct 29, 2025 · this disclosureCongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
What came next
- Nov 3, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 7, 2025Insider · 1 personInsiders: 4 sales (~$6.6M)
- Nov 12, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Dec 2, 2025CongressDisclosed partial sale of IDXX — reported range $1,001 - $15,000
- Jan 11, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 11, 2026, Jonathan (Jay) Mazelsky notified IDEXX Laboratories, Inc. (the “Company” or “IDEXX”) of his intent to step down as the Company’s President and Chief Executive Officer effective as of May 12, 2026 (the “Transition Date”) and retire from the Company and the Company’s Board of the Directors (the “Board”) immediately following the Company’s annual meeting of shareholders in May 2027 (the “Retirement…”
- Jan 13, 2026CongressDisclosed sale of IDXX — reported range $1,001 - $15,000
- Feb 2, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 10, 2026Insider · 1 personInsiders: 8 sales (~$7.3M)
- Feb 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 13, 2026, Ms. M. Anne Szostak provided IDEXX Laboratories, Inc. (the “Company”) notice of her intention to retire from the Board of Directors (the “Board”) effective immediately following the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”) to be held on May 12, 2026.”
- Feb 17, 2026Insider · 2 peopleInsiders: 8 sales (~$4.3M)
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Idexx Laboratories
For Idexx Laboratories, OQRO holds 29 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IDXX page.
Other recent filings by Rep. April McClain Delaney (MD06)
- House Clerk periodic transaction report at Corpay (CPAY)Sep 9, 2026
- House Clerk periodic transaction report at Middleby (MIDD)Sep 9, 2026
- House Clerk periodic transaction report at Tractor Supply (TSCO)Sep 9, 2026
- House Clerk periodic transaction report at Wabtec (WAB)Sep 9, 2026
- House Clerk periodic transaction report at Wabtec (WAB)Sep 9, 2026
The full history of Rep. April McClain Delaney (MD06) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Idexx Laboratories (IDXX) stock, and how much?
Rep. April McClain Delaney (MD06) disclosed a partial sale of Idexx Laboratories in the $1K–$15K range. Reported range, not an exact amount, Dependent child account.
When did it happen, and when was it made public?
Traded: Oct 29, 2025. Disclosed: Nov 4, 2025. That is 6 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Idexx Laboratories recently?
For Idexx Laboratories, OQRO holds 29 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the IDXX page.
Does this mean IDXX stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Idexx Laboratories
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 4Nov 5, 2026
Everything OQRO holds on this company is on its IDXX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
